• Welcome to Pharmacology

  • Image courtesy of the Feng Lab

  • Hippocampal CA1 4 days after status epilepticus in COX2 cKO. blue-cell nuclei; green-astrocytes; red-microglia. Courtesy of Dingledine lab

  • Image courtesy of the Hepler Lab

  • Image courtesy of the Pavlath Lab

  • Image courtesy of the Traynelis Lab

Department Focus

 Lab Image

Hippocampal CA3 4 days after status epilepticus. blue - cell nuclei; green -  astrocytes; red - microglia. Courtesy of Dingledine lab.

 Lab Image

Mouse dentate hilus region 4 days after status epilepticus. Blue = cell nuclei; green = astrocytes; red = microglia. Courtesy of Dingledine lab.

 Lab Image

Mouse hippocampal CA1 region 4 days after status epilepticus. Blue = cell nuclei; green = astrocytes; red = microglia. Courtesy of Dingledine lab.

Pavlath image

Image Courtesy of the Pavlath Lab

Feng Lab Image

Image Courtesy of the Feng Lab

Pavlath Lab Image

Image Courtesy of the Pavlath Lab

Feng Lab Image

Image courtesy of the Feng Lab

Feng Lab Image

Image Courtesy of the Feng Lab

Hepler Lab Image

Image courtesy of the Hepler Lab

 Lab Image

Mouse dentate hilus region 4 days after status epilepticus. Blue = cell nuclei; green = astrocytes; red = microglia. Courtesy of Dingledine lab.

Traynelis Lab image

Image Courtesy of the Traynelis Lab

Feng Lab Image

Image Courtesy of the Feng Lab

Dingledine Lab Image

Mouse hippocampal CA1 region 4 days after status epilepticus. Blue = cell nuclei; green = astrocytes; red = microglia. Courtesy of Dingledine lab.

Dingledine Lab Image

Mouse hippocampal CA1 region 4 days after status epilepticus. Blue = cell nuclei; green = astrocytes; red = microglia. Courtesy of Dingledine lab.

Latest News

View All News>>

 

Pharmacology Seminars

See All Seminars>>

Pharmacology Welcomes Dr. Haian Fu as Department Chair

Dr. Haian Fu

Haian Fu, PhD, has been named Chair of the Department of Pharmacology, effective September 1, 2017. Dr. Fu joined the School of Medicine in 1994, and is currently serving as Professor of Pharmacology and Associate Dean for Innovation and International Strategies. He holds additional roles at Winship Cancer Institute, serving as a Professor of Hematology and Medical Oncology, a Winship Partner in Research Endowed Chair, and Leader of the Discovery and Developmental Therapeutics Program. Fu has effectively been serving as co-chair of the Department of Pharmacology since March, along with Ray Dingledine, PhD. Fu will build upon an outstanding Pharmacology Department. Dr. Dingledine has held the role of Chair for 25 years since joining Emory in 1992 with a simple but compelling vision of bringing cellular and molecular biological approaches to department research programs. He will continue this research in the department.

Dr. Fu’s research interests include cancer biology and chemical biology, with a focus on targeting protein-protein interaction networks in cell signaling for therapeutic agent discovery and translational research. He actively collaborates with physician scientists, chemists and disease biologists to advance research to benefit patients, contributes to national initiatives by serving on the NCI Cancer Target Discovery & Development (CTD2) Network steering committee and the NCI Chemical Biology Consortium steering committee, and leads a global effort in promoting chemical biology. Fu is a co-founder, past president and current chair of the Board of Directors for the International Chemical Biology Society. Fu is a recognized as a collaborative research leader with more than $30 million federal funding as a PI or co-PI in the past two decades.

Learn More>>

News Highlights

Emory Receives Record $628 Million in External Research Funding for FY 2017 

Dr. Haian Fu

Emory's research funding from external funding agencies totaled $628 million for fiscal year 2016-2017. This marks the eighth consecutive year that research funding has exceeded $500 million. With an increase from $574.6 million in FY 2016, this total is the largest in Emory’s history. Federal agencies awarded $384 million, or more than 61% of the total, led by the NIH, with $320 million in awards. NIH funding represented more than 83% of total federal dollars awarded to Emory.

"Research funding at Emory has continued on a strong upward trajectory over the past decade due to the hard work of our dedicated research faculty, trainees, and administrative staff and the enthusiastic support for research from Emory's leadership,” says David Stephens, WHSC VP for research. Researchers in the WHSC received more than $584.8 million in FY 2017, or more than 93% of the university total, with $353.7 million in federal funding, including $307.7 million from the NIH. The medical school received $355.7 million, public health received $131.7 million, Yerkes received $79 million, and nursing received $15 million. Click here to read full story.


 

Haian Fu Appointed Winship Partner in Research Endowed Chair

Haian Fu

Congratulations to Winship investigator Haian Fu, PhD for being named the Winship Partner in Research Endowed Chair. A dedication ceremony to honor Fu took place February 23 with colleagues and friends in attendance. This endowed chair was established within Winship to support the overall achievements of Fu and his contributions to Winship, the Emory School of Medicine and Emory University.

Pictured: Raymond Dingledine, PhD, Walter J. Curran, Jr., MD, Haian Fu, PhD, and Christian P. Larsen, MD, DPhil.

Click here to read full story.

Dr. Ray Dingledine Honored

The Department of Pharmacology thanks Ray for 25 years of amazing leadership!To honor Ray, a special seminar and reception were held on November 3rd, 2017.  Dr. Stephen Traynelis introduced Ray with several historical photos. Ray delivered an inspirational lecture on “From There to Here and Beyond” .  

Click here to read full story.